Alaunos Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Alaunos Therapeutics, Inc. (TCRT) had Prepaid Expense and Other Assets, Current of $542.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $542.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $616.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $600.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $747.00K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $542.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $616.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $600.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $747.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $857.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $746.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.66M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.87M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.21M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.89M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.20M 10-K · filed 2025-03-31 |
| 2023-09-30 | $925.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $457.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $750.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $799.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $849.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.35M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.52M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.67M 10-K · filed 2023-03-07 |
| 2021-09-30 | $3.32M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $5.04M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $7.65M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.86M 10-K · filed 2022-03-30 |
| 2020-09-30 | $14.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.58M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.84M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $22.42M 10-K · filed 2021-03-01 |
| 2019-09-30 | $23.74M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $20.84M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $21.75M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $20.69M 10-K · filed 2020-03-02 |
| 2018-09-30 | $14.41M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $11.93M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $20.99M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $19.82M 10-K · filed 2019-03-05 |
| 2017-09-30 | $30.47M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $27.89M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $26.24M 10-Q · filed 2017-05-01 |
| 2016-12-31 | $23.81M 10-K · filed 2018-03-01 |
| 2016-09-30 | $20.97M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $17.69M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $14.48M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $11.36M 10-K · filed 2017-02-16 |
| 2015-09-30 | $8.27M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $4.44M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $857.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.14M 10-K · filed 2016-02-24 |
| 2014-09-30 | $1.48M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $991.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.59M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.95M 10-K · filed 2015-02-26 |
| 2013-09-30 | $3.19M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $4.07M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $4.83M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $6.91M 10-K · filed 2014-03-03 |
| 2012-09-30 | $7.24M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $9.05M 10-Q/A · filed 2012-08-28 |
| 2012-03-31 | $10.80M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $1.31M 10-K · filed 2013-03-18 |
| 2011-09-30 | $1.41M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $1.02M 10-Q/A · filed 2011-08-09 |
| 2010-12-31 | $424.00K 10-K · filed 2012-02-29 |
| 2010-09-30 | $352.00K 10-Q · filed 2011-08-01 |
| 2009-12-31 | $354.00K 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |